# The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol

> **NCT04272008** · PHASE1 · COMPLETED · sponsor: **TherapeuticsMD** · enrollment: 21 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Segesterone Acetate and Ethinyl Estradiol
- **OTHER:** Tampon

## Key facts

- **NCT ID:** NCT04272008
- **Lead sponsor:** TherapeuticsMD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-06
- **Primary completion:** 2021-06-08
- **Final completion:** 2021-06-08
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04272008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04272008, "The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04272008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*